AVANOS MEDICAL, INC Price to Free Cash Flow Ratio 2012-2022 | AVNS

Historical price to free cash flow ratio values for AVANOS MEDICAL, INC (AVNS) since 2012. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
AVANOS MEDICAL, INC Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2022-09-23 21.88 11.13
2022-06-30 27.34 $1.97 13.91
2022-03-31 33.50 $1.30 25.82
2021-12-31 34.67 $1.28 27.13
2021-09-30 31.20 $0.27 115.77
2021-03-31 43.74 $-0.43 0.00
2020-12-31 45.88 $-0.47 0.00
2020-09-30 33.22 $-3.03 0.00
2020-06-30 29.39 $-0.59 0.00
2020-03-31 26.93 $-0.96 0.00
2019-12-31 33.70 $-1.88 0.00
2021-06-30 36.37 $0.01 3531.07
2019-09-30 37.46 $-3.03 0.00
2019-06-30 43.61 $-4.13 0.00
2019-03-31 42.68 $-4.87 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $1.035B $0.745B
Avanos Medical Inc. operates as a medical technology company. It offers infection prevention, surgical, respiratory, digestive health and pain management solutions. Avanos Medical Inc., formerly known as Halyard Health Inc., is headquartered in Alpharetta, Georgia.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $204.040B 20.78
Edwards Lifesciences (EW) United States $52.534B 37.17
Alcon (ALC) Switzerland $29.415B 24.91
STERIS (STE) Ireland $16.731B 20.78
Teleflex (TFX) United States $9.732B 15.51
Fresenius Medical Care AG KGaA (FMS) Germany $8.433B 7.78
Penumbra (PEN) United States $7.007B 840.64
Globus Medical (GMED) United States $5.801B 29.59
Glaukos (GKOS) United States $2.385B 0.00
Integer Holdings (ITGR) United States $2.051B 16.04
Nevro (NVRO) United States $1.548B 0.00
Paragon 28 (FNA) United States $1.343B 0.00
Artivion (AORT) United States $0.537B 51.19